A PLP splicing abnormality is associated with an unusual presentation of PMD

被引:43
作者
Hobson, GM
Huang, Z
Sperle, K
Stabley, DL
Marks, HG
Cambi, F
机构
[1] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Dept Pediat, Philadelphia, PA 19107 USA
[3] Alfred I Dupont Hosp Children, Dept Res, Wilmington, DE USA
[4] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA
关键词
D O I
10.1002/ana.10320
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We report that a deletion of 19 base pairs (bp) in intron 3 of the proteolipid protein (PLP/DM20) gene causes a neurological disease characterized by mild developmental delay, followed by progressive decline of acquired motor and cognitive milestones. The clinical features are associated with mild delay in myelination demonstrated by magnetic resonance imaging studies and with ongoing demyelination and axonal loss demonstrated by magnetic resonance spectroscopy. We demonstrate that the purine-rich 19bp element regulates PLP-specific splice site selection in transient transfections of chimeric constructs into cultured oligodendrocytes. Runs of 4 and 5 Gs centered in the 19bp element are critical for efficient PLP-specific splicing. The intronic element is sequence specific in oligodendrocytes and is not a repressor of PLP-specific splicing in nonglial cells. These data support the conclusion that deletion of the 19bp purine-rich region in PLP intron 3 causes a reduction in PLP message and protein, which affects myelin stability and axonal integrity.
引用
收藏
页码:477 / 488
页数:12
相关论文
共 76 条
[1]  
Anderson TJ, 1998, J COMP NEUROL, V394, P506, DOI 10.1002/(SICI)1096-9861(19980518)394:4<506::AID-CNE8>3.0.CO
[2]  
2-5
[3]  
BARRES BA, 1993, DEVELOPMENT, V118, P283
[4]   GROWTH AND DIFFERENTIATION PROPERTIES OF O-2A PROGENITORS PURIFIED FROM RAT CEREBRAL HEMISPHERES [J].
BEHAR, T ;
MCMORRIS, FA ;
NOVOTNY, EA ;
BARKER, JL ;
DUBOISDALCQ, M .
JOURNAL OF NEUROSCIENCE RESEARCH, 1988, 21 (2-4) :168-180
[5]   DISRUPTION OF THE COMPACTED MYELIN SHEATH OF AXONS OF THE CENTRAL-NERVOUS-SYSTEM IN PROTEOLIPID PROTEIN-DEFICIENT MICE [J].
BOISON, D ;
STOFFEL, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) :11709-11713
[6]   Evidence for neuroaxonal injury in patients with proteolipid protein gene mutations [J].
Bonavita, S ;
Schiffmann, R ;
Moore, DF ;
Frei, K ;
Choi, B ;
Patronas, N ;
Virta, A ;
Boespflüg-Tanguy, O ;
Tedeschi, G .
NEUROLOGY, 2001, 56 (06) :785-788
[7]   Computational analysis of candidate intron regulatory elements for tissue-specific alternative pre-mRNA splicing [J].
Brudno, M ;
Gelfand, MS ;
Spengler, S ;
Zorn, M ;
Dubchak, I ;
Conboy, JG .
NUCLEIC ACIDS RESEARCH, 2001, 29 (11) :2338-2348
[8]   REGULATION OF ALTERNATIVE SPLICING IN-VIVO BY OVEREXPRESSION OF ANTAGONISTIC SPLICING FACTORS [J].
CACERES, JF ;
STAMM, S ;
HELFMAN, DM ;
KRAINER, AR .
SCIENCE, 1994, 265 (5179) :1706-1709
[9]   Refined genetic mapping and proteolipid protein mutation analysis in X-linked pure hereditary spastic paraplegia [J].
Cambi, F ;
Tang, XM ;
Cordray, P ;
Fain, PR ;
Keppen, LD ;
Barker, DF .
NEUROLOGY, 1996, 46 (04) :1112-1117
[10]   DM20 MESSENGER-RNA SPLICE PRODUCT OF THE MYELIN PROTEOLIPID PROTEIN GENE IS EXPRESSED IN THE MURINE HEART [J].
CAMPAGNONI, CW ;
GARBAY, B ;
MICEVYCH, P ;
PRIBYL, T ;
KAMPF, K ;
HANDLEY, VW ;
CAMPAGNONI, AT .
JOURNAL OF NEUROSCIENCE RESEARCH, 1992, 33 (01) :148-155